EPA
EPA is a behavioral intervention with 9 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
3
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life
Differential Thrombogenesis by EPA and DHA Mediated by HDL
Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
Clinical Trials (9)
Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life
Differential Thrombogenesis by EPA and DHA Mediated by HDL
Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
Impact of Smoking Information on Concerns About Radon
Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
Time and Dose Evaluation of Stearidonic Acid (SDA) to Eicosapentaenoic Acid (EPA) in Red Blood Cells
All 9 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 9